Questions & explanations
1. Compare the organ failure patterns in pancreatitis vs. trauma-induced MOF.
In pancreatitis-induced MOF, the lungs and kidneys are most commonly affected, similar to trauma. However, pancreatitis often causes more severe abdominal complications like pancreatic necrosis and infected collections, which can drive ongoing inflammation. Trauma-induced MOF often starts with hemorrhagic shock and has a more sudden onset. Both can cause cardiovascular failure from low blood pressure. For example, a pancreatitis patient may develop kidney failure from fluid loss into the abdomen, while a trauma patient may have kidney failure from blood loss. Treatment differs: pancreatitis may need endoscopic drainage, while trauma needs bleeding control.
2. Compare plasmapheresis with other immunomodulatory therapies like corticosteroids in MOF.
Plasmapheresis physically removes inflammatory molecules, while corticosteroids suppress the immune system's production of those molecules. Plasmapheresis works quickly but is invasive and requires special equipment. Corticosteroids are easier to give but can increase infection risk. In multi-organ failure (MOF), plasmapheresis is used for severe cytokine storms, like in hemophagocytic lymphohistiocytosis (HLH). Corticosteroids are more common for general inflammation. Both have risks: plasmapheresis can cause bleeding, and steroids can raise blood sugar. The choice depends on the cause of MOF and the patient's condition.
3. Compare MARS and plasma exchange for treating liver failure in MOF.
Both MARS and plasma exchange remove toxins from the blood in liver failure. MARS uses a filter with albumin to selectively remove protein-bound toxins, while plasma exchange replaces all plasma. MARS is more targeted and does not remove beneficial proteins like clotting factors, but it is slower. Plasma exchange quickly lowers toxin levels and adds missing proteins, but it also removes helpful substances and requires donor plasma. In multi-organ failure (MOF), MARS may be better for patients who can tolerate longer treatment, while plasma exchange is used for rapid detoxification. Both are bridges to transplant.
4. How does stress hyperglycemia differ from diabetes in MOF?
Stress hyperglycemia is high blood sugar that happens during critical illness due to stress hormones like cortisol and adrenaline. It is temporary and goes away when the illness resolves. Diabetes is a chronic condition where the body cannot control blood sugar normally. In MOF, both conditions can occur together. Stress hyperglycemia often requires more insulin than usual for a diabetic patient. It is important to treat stress hyperglycemia because it worsens outcomes, but the target range is the same (140-180 mg/dL). After recovery, blood sugar may return to normal if the patient did not have diabetes before.
5. What is acute hydrocephalus?
Acute hydrocephalus is a sudden buildup of cerebrospinal fluid (CSF) inside the brain's ventricles, causing increased pressure. It is a medical emergency that requires prompt drainage to prevent brain damage. The most common causes are bleeding in the brain (like subarachnoid hemorrhage) or infection. An external ventricular drain (EVD) is a tube placed into the ventricle to drain excess CSF and monitor intracranial pressure (ICP). EVD insertion is done by a neurosurgeon at the bedside or in the operating room. The drain helps control ICP and can also be used to give medicine directly into the CSF.
6. What are the indications for starting ECMO in MOF?
ECMO is started when a patient has severe respiratory or cardiac failure that does not improve with standard treatments. For lung failure, indications include very low oxygen levels (PaO2/FiO2 < 80) or high carbon dioxide despite a ventilator. For heart failure, it is used when blood pressure stays low despite strong medicines (vasopressors). In multi-organ failure (MOF), ECMO is considered if the patient is young and has a reversible cause, like severe pneumonia or a heart attack. It is not used if there is severe brain damage or untreatable cancer. The goal is to buy time for organs to heal.
7. Compare the use of succinylcholine and rocuronium for RSI. Which one is preferred in certain situations?
Succinylcholine is a depolarizing paralytic that works in 30-60 seconds and lasts 5-10 minutes. It is preferred when rapid onset and short duration are needed, but it can cause hyperkalemia (high potassium) in patients with burns, renal failure, or nerve injuries. Rocuronium is a non-depolarizing paralytic that works in 60-90 seconds and lasts 30-60 minutes. It is safer in hyperkalemia but has longer duration. Sugammadex can reverse rocuronium quickly. The choice depends on patient factors: succinylcholine is classic for RSI, but rocuronium is used when succinylcholine is contraindicated.
8. A patient scores positive on the ICDSC for delirium. What does this mean and what is the next step?
The ICDSC (Intensive Care Delirium Screening Checklist) has 8 items, each scored 0 or 1, with a total of 4 or more indicating delirium. A positive score means the patient has delirium, which is a brain dysfunction causing confusion and hallucinations. The next step is to look for underlying causes: check for infection, electrolyte imbalances, withdrawal from alcohol or drugs, and review medications that can cause delirium. Non-drug measures like reorientation, family visits, and early mobility are started. If the patient is agitated, low-dose antipsychotics like haloperidol may be used.
9. What should an ICU doctor do if a family refuses a treatment that is medically necessary due to cultural reasons?
The doctor should first listen respectfully to the family's reasons and try to understand their cultural perspective. They can explain the medical benefits and risks clearly, without dismissing the family's beliefs. Involving a cultural mediator or religious leader may help find a compromise. For example, if a family refuses a blood transfusion due to religious beliefs, the team can explore alternatives like medications to raise blood counts. If no agreement is reached, the ethics committee can help. The goal is to respect the family's values while advocating for the patient's health.
10. What is a genetic polymorphism?
A genetic polymorphism is a variation in DNA sequence that occurs in at least 1% of the population. These variations can affect how the immune system responds to injury or infection. In multi-organ failure (MOF), certain polymorphisms in genes for cytokines like TNF-alpha or interleukins can make a person more likely to develop severe organ damage. For example, a common polymorphism in the TNF-alpha gene increases its production, leading to stronger inflammation. This stronger inflammation can cause more organ failure. So, genetic testing might help identify high-risk patients early.
11. What are common complications of ECMO in MOF patients?
Common complications include bleeding from the need for blood thinners (heparin) to prevent clots in the circuit. This can cause bleeding at the insertion sites or in the brain. Infection is another risk because the catheters can introduce bacteria. Mechanical problems like oxygenator failure or pump malfunction can occur. In multi-organ failure (MOF), patients are already fragile, so bleeding and infection can worsen organ damage. Also, VA ECMO can cause leg ischemia (lack of blood flow) on the side of the artery catheter. Careful monitoring and experienced teams reduce these risks.
12. What is sepsis in an immunocompromised host?
Sepsis is a life-threatening condition where the body's response to an infection damages its own tissues. In immunocompromised hosts, such as people with HIV, cancer, organ transplant, or low white blood cells (neutropenia), the immune system is weak. This means they may not show typical signs like fever, making sepsis harder to spot. Common infections come from bacteria, fungi, or viruses that a healthy immune system would control. Because their defenses are low, sepsis can progress faster and be more severe. Doctors often start broad antibiotics early and check for unusual germs.